- Published on
Emergency and Acute Medicine – Torticollis
Torticollis, meaning “twisted neck,” is a clinical symptom rather than a disease entity. It refers to a fixed or dynamic abnormal posture of the head and neck, often involving rotation or tilting. It is also known as cervical dystonia or wry neck and may arise from a wide range of local or central causes.
The etiology of torticollis is broad and can be categorized into local and central causes. The most common form is acute wry neck, which typically develops अचानक (often overnight) without clear provocation and resolves spontaneously within 1–2 weeks. Local structural causes include cervical spine pathology such as fractures, dislocations, subluxations, spondylosis, tumors, ligamentous laxity (especially in the atlantoaxial region), and scar tissue from prior injury. Inflammatory or infectious causes include myositis, lymphadenitis, tuberculosis, and infections of surrounding tissues such as retropharyngeal abscess, meningitis, tonsillitis, mastoiditis, or sinusitis. Neurologic and neuromuscular causes include myasthenia gravis and neuritis. Compensatory torticollis may occur with ocular muscle palsy or head tremor.
Central causes include idiopathic spasmodic torticollis, which is more common in women aged 31–60 years, as well as dystonic disorders such as torsion dystonia, tardive dystonia from neuroleptic medications, Wilson disease, and toxic causes such as Strychnine poisoning. Drug-induced dystonia, particularly from antipsychotics, is a common acute cause and typically occurs within 12–23 hours of medication exposure.
In pediatric patients, causes include congenital abnormalities such as muscular torticollis due to sternocleidomastoid hypertrophy, vertebral anomalies, or syndromic conditions. Other causes include infections (e.g., otitis media, retropharyngeal abscess), trauma, gastroesophageal reflux, and central nervous system pathology such as posterior fossa tumors.
Clinically, patients present with intermittent or sustained painful spasms of the neck muscles, particularly the sternocleidomastoid and trapezius. The head is typically rotated and tilted to one side, with movements ranging from smooth deviation to jerking motions. Pure flexion (anterocollis) or extension (retrocollis) is uncommon. Symptoms are often exacerbated by activity, stress, or upright posture and typically resolve during sleep.
History should focus on recent trauma, medication exposure (especially antipsychotics), and systemic symptoms such as fever. On examination, the abnormal head posture is evident, and neurologic evaluation is essential. The presence of fever suggests an infectious cause, while focal neurologic deficits raise concern for central nervous system or spinal cord pathology. In congenital cases, a firm, nontender mass in the sternocleidomastoid muscle may be present.
Evaluation is directed at excluding serious causes. Cervical spine imaging is indicated when trauma is suspected. CT or MRI may be required if there is concern for abscess, tumor, or neurologic pathology. Ultrasound is the preferred modality for congenital muscular torticollis. No specific laboratory tests are routinely helpful.
Management depends on the underlying cause. Prehospital care includes ensuring airway patency, supporting the head, and maintaining cervical spine precautions if trauma is suspected. In the emergency setting, immobilization is essential when fracture is a concern.
For drug-induced torticollis, treatment with diphenhydramine or benztropine is highly effective. For non-drug-related cases, conservative management includes rest, soft cervical collar, physical therapy, massage, local heat, and analgesics. Benzodiazepines may be used for muscle relaxation. Botulinum toxin is the first-line treatment for chronic or non–drug-induced torticollis, although it is typically administered in an outpatient setting.
Patients require admission if there is suspicion of cervical spine fracture, infection, toxic appearance, inability to maintain hydration, or diagnostic uncertainty. Most uncomplicated cases can be managed as outpatients with referral to specialists such as neurologists, orthopedists, or neurosurgeons.
Key clinical pearls include always excluding serious causes such as infection (e.g., retropharyngeal abscess or meningitis), trauma, and central nervous system pathology before attributing symptoms to benign torticollis. Drug-induced dystonia is common and rapidly reversible with appropriate treatment, and failure to recognize life-threatening causes can lead to significant morbidity.
- Published on
Emergency and Acute Medicine – Toothache
Toothache is a common presentation caused by irritation of the nerve endings within the dental pulp, which contains the tooth’s neurovascular supply. Although most causes are odontogenic, pain may also originate from non-dental sources and be referred to the oral cavity via the distribution of the trigeminal nerve.
The most common etiologies are dental in origin. Dental caries, resulting from bacterial demineralization of tooth structures, can progress to pulpitis, which may be reversible or irreversible depending on severity. Reversible pulpitis causes mild inflammation and transient pain, whereas irreversible pulpitis leads to severe, persistent, and poorly localized pain. If untreated, this may progress to a periapical abscess involving necrotic pulp and surrounding tissues. Other dental causes include periodontal disease (gingivitis and periodontitis), periodontal abscess, pericoronitis (often associated with partially erupted wisdom teeth), cracked-tooth syndrome, postextraction complications such as dry socket, and mucosal conditions such as aphthous ulcers or herpetic gingivostomatitis.
Patients typically present with localized or referred tooth pain that may radiate to the jaw, ear, face, eye, or neck. The pain is often exacerbated by chewing, temperature changes, or lying flat. Associated symptoms may include foul taste, bad breath, fever, or facial swelling. A detailed history should include onset, duration, prior treatments, and associated systemic symptoms.
Physical examination should be thorough and systematic. Findings may include visible dental decay, gingival inflammation, swelling, or trismus (reduced mouth opening). The clinician should inspect and palpate oral structures, assess for lymphadenopathy, and evaluate for signs of deep-space infection such as floor-of-mouth swelling or voice changes. Percussion of teeth may reveal tenderness, and examination for fractures, mobility, or missing teeth is essential. Facial and neck examination should assess for cellulitis, warmth, and stiffness.
Diagnosis is primarily clinical. Laboratory tests are generally not required unless there are signs of systemic toxicity or deep-space infection, in which case inflammatory markers and cultures may be considered. Imaging such as panoramic or periapical radiographs may help identify abscesses or fractures, while CT or MRI is reserved for suspected deep infections. Dental nerve blocks can provide both diagnostic and therapeutic benefit in selected cases.
Management focuses on pain control and treatment of the underlying cause. NSAIDs are first-line therapy for uncomplicated dental pain, with opioids reserved for severe cases. Local or regional dental nerve blocks using long-acting anesthetics such as bupivacaine can provide effective relief. If infection is present, antibiotics are indicated, with penicillin as first-line therapy and clindamycin for penicillin-allergic patients or suspected anaerobic infections.
Localized abscesses should be incised, drained, and irrigated, followed by saline rinses and prompt dental follow-up. Most patients can be discharged with appropriate analgesia, antibiotics if indicated, and referral to a dentist or oral surgeon. However, admission is required for serious complications such as deep-space infections (e.g., Ludwig angina), facial cellulitis near the eye, significant trismus, inability to maintain hydration, or systemic toxicity.
Key clinical pearls include recognizing that dental pain can be referred from non-dental sources such as sinusitis, temporomandibular joint disorders, or even cardiac ischemia. Failure to identify deep-space infections can lead to life-threatening complications, so careful assessment is essential. Prompt dental follow-up is critical, as emergency department treatment is only temporizing and does not address the definitive underlying pathology.
- Published on
Emergency and Acute Medicine – Toluene Poisoning
Toluene poisoning results from exposure to a volatile hydrocarbon that is a clear, colorless liquid with a characteristic sweet odor. It is widely used as an organic solvent in products such as paints, thinners, glues, inks, correction fluid, petroleum products, and aerosolized household items. Exposure may occur occupationally or through intentional abuse, particularly among adolescents due to its low cost and easy accessibility. Methods of abuse include sniffing directly from a container, huffing vapors from a soaked cloth, and bagging vapors in a confined space for inhalation.
Toluene is rapidly absorbed through inhalation and readily crosses the blood–brain barrier, achieving high concentrations in the brain. It exerts multiple toxic effects, including central nervous system depression, myocardial sensitization to catecholamines, and disruption of cardiac ion channels, predisposing to dangerous dysrhythmias. It is metabolized in the liver and excreted through the lungs and urine. Toxicity is dose-dependent, ranging from mild impairment at lower concentrations to anesthesia, seizures, and death at very high levels.
Clinically, acute toxicity primarily affects the neurologic, cardiac, pulmonary, and metabolic systems. Patients may present with euphoria, dizziness, ataxia, confusion, or seizures. Cardiac effects are particularly dangerous and include potentially fatal dysrhythmias, especially in the setting of catecholamine surges (“sudden sniffing death”). Pulmonary complications include chemical pneumonitis and pulmonary edema. Metabolic abnormalities are characteristic and include hypokalemia, hypocalcemia, and a hyperchloremic metabolic acidosis due to accumulation of hippuric acid. Gastrointestinal symptoms such as nausea, vomiting, and abdominal pain may occur, and renal effects include distal renal tubular acidosis, hematuria, and proteinuria.
Chronic exposure leads to progressive and often irreversible damage. Neurologic complications include peripheral neuropathy, leukoencephalopathy, cerebellar dysfunction, and cognitive impairment. Cardiac complications may include dilated cardiomyopathy and persistent dysrhythmias. Renal injury may progress to chronic failure, and musculoskeletal complications such as rhabdomyolysis can occur. Chronic abuse is also associated with psychiatric issues and addiction. In pregnancy, chronic exposure has been linked to fetal solvent syndrome, resembling fetal alcohol syndrome with growth restriction and developmental delay.
Diagnosis is primarily clinical, supported by history of exposure and physical findings such as solvent odor, perioral dermatitis, or evidence of inhalant use on clothing or skin. Laboratory evaluation typically reveals electrolyte abnormalities, particularly hypokalemia and metabolic acidosis. Renal function tests, creatine kinase (if rhabdomyolysis is suspected), and liver function tests should be obtained. Urinary hippuric acid may confirm exposure but does not correlate with severity. Imaging studies include ECG to detect dysrhythmias and chest radiography if respiratory symptoms are present.
Management focuses on supportive care and stabilization. Initial priorities include airway, breathing, and circulation, with supplemental oxygen, cardiac monitoring, and intravenous fluids. Sudden cardiac death is a major risk due to myocardial sensitization, so careful monitoring is essential. Dysrhythmias should be treated according to standard protocols, with consideration of β-blockers for tachydysrhythmias. Respiratory status should be monitored closely, and chemical pneumonitis is managed supportively, as steroids are not recommended.
Metabolic abnormalities should be corrected, including cautious repletion of potassium, calcium, and phosphate. Acidosis generally improves with fluid resuscitation. In cases of rhabdomyolysis, aggressive hydration is required to maintain urine output. Gastrointestinal decontamination is generally not useful and may increase the risk of aspiration; activated charcoal is ineffective for hydrocarbons.
Disposition depends on clinical severity. Patients with altered mental status, dysrhythmias, significant metabolic disturbances, renal failure, or rhabdomyolysis require admission. Those who return to baseline mental status and remain stable after 4–6 hours of observation without evidence of complications may be discharged.
Key clinical pearls include the risk of sudden death due to catecholamine-induced dysrhythmias and the importance of monitoring and correcting electrolyte abnormalities. Cardiac complications carry a poor prognosis, and cessation of exposure is the most important long-term intervention. Referral for psychiatric evaluation and substance abuse counseling is essential in cases of intentional or repeated use.
- Published on
Ophthalmology – Branch Retinal Vein Occlusion (BRVO)
Branch retinal vein occlusion (BRVO) is a retinal vascular disorder characterized by obstruction of blood flow in a branch retinal vein, typically at an arteriovenous crossing. It commonly presents with painless, variable vision loss, which may be blurred or distorted. Clinically, BRVO is classified into ischemic and nonischemic types, which differ in severity, prognosis, and risk of complications. It primarily affects individuals over 50 years of age, while pediatric cases are rare and often associated with identifiable systemic causes such as hypercoagulable states.
Epidemiologically, BRVO is the second most common retinal vascular disorder after diabetic retinopathy and is more common than central retinal vein occlusion. Its incidence increases with age, with a 15-year cumulative incidence of approximately 1.8% reported in population studies. The overall prevalence ranges from 0.6% to 1.6%, affecting both men and women equally.
The strongest risk factor for BRVO is systemic hypertension, present in the majority of patients. Other important risk factors include diabetes mellitus, hyperlipidemia, obesity, cardiovascular disease, and hyperviscosity syndromes. In younger patients, evaluation for thrombophilia or systemic disease is essential, as BRVO is less commonly idiopathic in this group.
Pathophysiologically, BRVO is believed to result from mechanical compression of a retinal vein by an adjacent artery at arteriovenous crossing points, where both share a common sheath. This leads to turbulent flow, endothelial injury, and thrombus formation—components of Virchow’s triad. The resulting venous obstruction causes increased hydrostatic pressure, retinal hemorrhage, and capillary leakage. Hypoxia stimulates increased production of vascular endothelial growth factor (VEGF), contributing to macular edema and neovascularization, which are major causes of vision loss.
Patients typically present with sudden or gradual vision loss, depending on the extent and location of involvement. Fundus examination reveals sectoral flame-shaped hemorrhages in the distribution of the affected vein, along with dilated and tortuous vessels. Additional findings may include cotton wool spots, microaneurysms, retinal edema, and, in chronic stages, collateral vessel formation and retinal pigment epithelial changes. The superotemporal quadrant is most commonly affected.
Diagnosis is primarily clinical, supported by imaging. Fluorescein angiography demonstrates delayed venous filling, leakage, and areas of capillary nonperfusion, particularly in ischemic BRVO (defined as greater than five disc areas of nonperfusion). Optical coherence tomography (OCT) is essential for detecting and monitoring macular edema. Laboratory investigations are generally unnecessary in older patients with known vascular risk factors but are important in younger patients to evaluate for systemic or hypercoagulable conditions.
Management focuses on treating complications such as macular edema and neovascularization. First-line therapy includes intravitreal anti-VEGF agents such as bevacizumab, ranibizumab, or dexamethasone implants, which reduce edema and improve visual outcomes. Historically, macular grid laser photocoagulation was used for persistent edema, and it remains an option in selected cases. Panretinal photocoagulation is indicated for neovascular complications but is not used prophylactically. In refractory cases, surgical options such as vitrectomy may be considered.
Patients require close follow-up, typically monthly for the first three months and then at regular intervals, with monitoring using OCT, fluorescein angiography, and visual field testing. Coordination with a primary care physician is important to manage systemic risk factors and prevent recurrence or progression.
The prognosis for BRVO is generally favorable, with about half of patients achieving visual acuity of 20/40 or better. However, outcomes vary depending on the extent of ischemia, presence of macular edema, and development of complications. Conversion from nonischemic to ischemic BRVO can occur, making prognosis unpredictable. Major complications include macular edema, macular ischemia, retinal neovascularization, and vitreous hemorrhage, all of which can significantly impact vision.
- Published on
Ophthalmology – Bartonella Neuroretinitis
Bartonella neuroretinitis is a form of neuroretinitis characterized by optic disc swelling accompanied by a distinctive pattern of hard exudates radiating from the macula in a “macular star” configuration. The most common infectious cause is Bartonella henselae, a gram-negative bacillus associated with cat-scratch disease. While neuroretinitis can result from various infectious and inflammatory conditions, Bartonella infection remains the leading identifiable etiology.
This condition can affect individuals of all ages but is most commonly seen in patients in their third to fourth decades of life. There is no clear gender predilection. A key risk factor is exposure to cats, particularly kittens, as transmission typically occurs through scratches or bites. Other infectious causes of neuroretinitis include syphilis, viral infections, toxoplasmosis, toxocariasis, histoplasmosis, and Lyme disease. Noninfectious causes such as sarcoidosis may also present similarly and should be considered in the differential diagnosis.
Patients typically present with visual complaints such as blurred vision and eye discomfort, often worsened by eye movement. Systemic symptoms may accompany the ocular findings, especially in cases related to cat-scratch disease, and can include fever, malaise, headache, and muscle aches. A detailed history is important, including animal exposure, travel, dietary habits, and sexual history, to help identify potential infectious etiologies.
On examination, visual acuity can range widely from normal to severely reduced, even to light perception in some cases. Common findings include decreased color vision, a relative afferent pupillary defect, and optic disc edema. The hallmark feature is the presence of macular hard exudates arranged in a star pattern around the fovea. Additional findings may include splinter hemorrhages, retinal vascular occlusions, small yellow-white retinal or choroidal infiltrates, and vitreous inflammation. In systemic Bartonella infection, patients may also exhibit lymphadenopathy, arthritis, or neurologic involvement such as meningitis or encephalitis.
Diagnosis is primarily clinical but supported by laboratory and imaging studies. Serologic testing for Bartonella henselae is commonly used, with ELISA being widely available. Testing for other infectious causes should be performed as indicated. Fluorescein angiography typically demonstrates optic disc leakage and staining of peripapillary vessels. Visual field testing often reveals a cecocentral scotoma, which is the most common defect associated with this condition.
The differential diagnosis includes optic neuritis and other forms of optic neuropathy, which may present with similar visual symptoms but lack the characteristic macular star. Identifying the underlying cause is crucial for appropriate management.
Treatment of Bartonella neuroretinitis generally involves antibiotic therapy. First-line treatment for cat-scratch disease includes oral ciprofloxacin, although other antibiotics such as azithromycin, doxycycline, erythromycin, or rifampin may also be used depending on clinical circumstances. Patients should be co-managed with a primary care physician or infectious disease specialist, in addition to close ophthalmologic follow-up.
The prognosis is typically favorable, as Bartonella neuroretinitis is often self-limited. Optic disc swelling usually resolves within 6 to 8 weeks, while macular exudates may take 6 to 12 months to fully resolve. Some patients may experience persistent visual symptoms such as mild blurring or metamorphopsia, and residual optic disc pallor can occur. Recurrence is uncommon. Potential complications include permanent visual loss and systemic complications related to the underlying infectious or inflammatory condition.
- Published on
Ophthalmology – Blind Baby
Blindness in infants is defined by the World Health Organization as a corrected visual acuity of 20/200 or worse in the better eye, or a visual field restricted to 10 degrees or less around central fixation. Childhood blindness is a significant global health issue, with marked variation depending on socioeconomic and environmental conditions. In developed countries, the incidence is approximately 0.3 per 1,000 children under five years, while globally it is higher, and an estimated 1.4 million children were blind worldwide as of 2000. Underprivileged regions bear a disproportionately higher burden due to preventable causes.
Risk factors for infant blindness span prenatal, perinatal, and childhood periods. Prenatal risks include genetic predisposition and maternal infections such as rubella, toxoplasmosis, cytomegalovirus, herpes simplex virus, and syphilis, as well as exposure to drugs or toxins. Prematurity is a major contributor in developed countries. Perinatal risks include hypoxia, infection, and trauma, while postnatal risks include malnutrition (especially vitamin A deficiency), infections, trauma, and systemic or neurological diseases. Genetic eye diseases and syndromic associations are among the leading causes overall.
The underlying mechanisms of blindness involve either structural abnormalities of the eye or visual pathways, or functional impairment such as amblyopia or cortical visual impairment. Causes may affect any part of the visual system, including the globe (e.g., anophthalmia, microphthalmia), cornea (opacities), lens (cataract), retina (retinopathy of prematurity, dystrophies), optic nerve (hypoplasia, atrophy), or brain (hypoxic injury, tumors, developmental anomalies). Associated systemic and infectious conditions are common, particularly congenital infections and syndromic disorders.
Diagnosis begins with careful history-taking, including family history of eye disease, maternal prenatal exposures, birth history, and developmental milestones. Clinically, infants may show signs such as poor eye contact, nystagmus, wandering eye movements, lack of fixation, or behaviors like eye poking (oculodigital sign). Examination includes assessment for structural abnormalities such as corneal opacity, cataract, retinal pathology, or optic nerve anomalies, as well as evaluation for systemic conditions.
Investigations are guided by suspected etiology. Imaging such as MRI may be used when optic nerve or cortical causes are suspected, while ocular ultrasound helps evaluate anatomy when media opacities are present. Electrophysiological testing can help assess retinal or cortical function when clinical findings are unclear. In some cases, examination under anesthesia is necessary for a complete assessment.
Management depends on the underlying cause but emphasizes early intervention. Treatable causes such as cataract, glaucoma, or retinopathy of prematurity require prompt surgical or medical treatment. Refractive errors should be corrected, and amblyopia therapy initiated when appropriate. Supportive care is crucial and includes low vision rehabilitation, mobility training, and individualized educational planning. Referral to specialists such as geneticists, pediatricians, and infectious disease experts is often required.
Prevention plays a major role, as up to half of childhood blindness is avoidable. Strategies include improving maternal health and prenatal care, preventing infections, reducing premature births, early screening for ocular conditions, and addressing nutritional deficiencies. Public health education and genetic counseling are also key components.
The prognosis varies widely depending on the cause and access to early diagnosis and treatment. With timely intervention and supportive care, many children can achieve improved functional vision and quality of life.
Ophthalmology – Blind Baby
Blindness in infants is defined by the World Health Organization as a corrected visual acuity of 20/200 or worse in the better eye, or a visual field restricted to 10 degrees or less around central fixation. Childhood blindness is a significant global health issue, with marked variation depending on socioeconomic and environmental conditions. In developed countries, the incidence is approximately 0.3 per 1,000 children under five years, while globally it is higher, and an estimated 1.4 million children were blind worldwide as of 2000. Underprivileged regions bear a disproportionately higher burden due to preventable causes.
Risk factors for infant blindness span prenatal, perinatal, and childhood periods. Prenatal risks include genetic predisposition and maternal infections such as rubella, toxoplasmosis, cytomegalovirus, herpes simplex virus, and syphilis, as well as exposure to drugs or toxins. Prematurity is a major contributor in developed countries. Perinatal risks include hypoxia, infection, and trauma, while postnatal risks include malnutrition (especially vitamin A deficiency), infections, trauma, and systemic or neurological diseases. Genetic eye diseases and syndromic associations are among the leading causes overall.
The underlying mechanisms of blindness involve either structural abnormalities of the eye or visual pathways, or functional impairment such as amblyopia or cortical visual impairment. Causes may affect any part of the visual system, including the globe (e.g., anophthalmia, microphthalmia), cornea (opacities), lens (cataract), retina (retinopathy of prematurity, dystrophies), optic nerve (hypoplasia, atrophy), or brain (hypoxic injury, tumors, developmental anomalies). Associated systemic and infectious conditions are common, particularly congenital infections and syndromic disorders.
Diagnosis begins with careful history-taking, including family history of eye disease, maternal prenatal exposures, birth history, and developmental milestones. Clinically, infants may show signs such as poor eye contact, nystagmus, wandering eye movements, lack of fixation, or behaviors like eye poking (oculodigital sign). Examination includes assessment for structural abnormalities such as corneal opacity, cataract, retinal pathology, or optic nerve anomalies, as well as evaluation for systemic conditions.
Investigations are guided by suspected etiology. Imaging such as MRI may be used when optic nerve or cortical causes are suspected, while ocular ultrasound helps evaluate anatomy when media opacities are present. Electrophysiological testing can help assess retinal or cortical function when clinical findings are unclear. In some cases, examination under anesthesia is necessary for a complete assessment.
Management depends on the underlying cause but emphasizes early intervention. Treatable causes such as cataract, glaucoma, or retinopathy of prematurity require prompt surgical or medical treatment. Refractive errors should be corrected, and amblyopia therapy initiated when appropriate. Supportive care is crucial and includes low vision rehabilitation, mobility training, and individualized educational planning. Referral to specialists such as geneticists, pediatricians, and infectious disease experts is often required.
Prevention plays a major role, as up to half of childhood blindness is avoidable. Strategies include improving maternal health and prenatal care, preventing infections, reducing premature births, early screening for ocular conditions, and addressing nutritional deficiencies. Public health education and genetic counseling are also key components.
The prognosis varies widely depending on the cause and access to early diagnosis and treatment. With timely intervention and supportive care, many children can achieve improved functional vision and quality of life.
- Published on
Ophthalmology – Blepharospasm and Hemifacial Spasm
Blepharospasm and hemifacial spasm are movement disorders involving involuntary contractions of facial muscles. Blepharospasm refers to bilateral, involuntary eyelid closure due to spasms of the eyelid muscles, while hemifacial spasm involves unilateral contractions of muscles supplied by the facial nerve. These conditions primarily affect the nervous and musculoskeletal systems and are most commonly seen in middle-aged adults, with a higher prevalence in women.
Blepharospasm may be classified as essential (idiopathic), associated with dystonia (such as Meige syndrome, which involves the face, jaw, and neck), or secondary to ocular irritation such as dry eye or inflammation. Hemifacial spasm, on the other hand, is typically caused by vascular compression of the facial nerve, although rarely tumors in the posterior fossa may be responsible.
The pathophysiology of blepharospasm involves abnormal simultaneous contraction of opposing muscle groups: the eyelid protractors (such as the orbicularis oculi) and retractors (such as the levator palpebrae). There may also be increased sensitivity of the trigeminal system, particularly in patients with photophobia. In hemifacial spasm, abnormal nerve transmission (ephaptic transmission) occurs due to irritation or compression of the facial nerve, leading to synchronous contractions of facial muscles.
Clinically, patients with blepharospasm initially experience increased blinking, which progresses to involuntary, forceful eyelid closure that may become disabling. Symptoms may begin unilaterally but usually become bilateral. Ocular irritation is often present. In hemifacial spasm, patients develop intermittent twitching around one eye that gradually spreads to involve other muscles on the same side of the face. These spasms are typically synchronous and persist during sleep in some cases.
On examination, blepharospasm is characterized by nonvolitional contraction of multiple eyelid muscles, not just the orbicularis. It is important to exclude underlying ocular causes such as dry eye or eyelid abnormalities. Hemifacial spasm presents with coordinated, unilateral contractions of facial muscles. Neuroimaging, particularly MRI or MRA of the brain with attention to the posterior fossa, is recommended to evaluate for vascular compression or other structural causes.
Treatment focuses on symptom control. Botulinum toxin injections are the first-line therapy for both conditions and are highly effective, with about 90% of patients experiencing improvement. These injections are typically administered every 3–4 months. Oral medications such as carbamazepine, baclofen, or clonazepam may be used but are often less effective and can cause sedation. In cases of hemifacial spasm due to vascular compression, microvascular decompression surgery may be considered. Surgical options for blepharospasm, such as orbicularis myectomy, are reserved for refractory cases.
Regular follow-up is important, especially after botulinum injections, to assess response and determine the timing of repeat treatment. Patients should be educated about the chronic nature of these conditions and reassured that effective treatment options are available. Reducing triggers such as stress or excessive caffeine intake may help in some cases.
The prognosis is generally favorable, particularly with botulinum toxin therapy. However, untreated or severe cases can significantly impact quality of life due to functional visual impairment. Surgical interventions, while effective in selected cases, carry risks such as facial weakness or hearing loss, particularly in procedures involving the facial nerve.
- Published on
Ophthalmology – Blepharitis
Blepharitis is a chronic, recurrent inflammation of the eyelid margin and is one of the most common conditions encountered in ophthalmology practice. It is broadly divided into two types: anterior blepharitis (also called seborrheic blepharitis), which affects the front of the eyelid at the base of the eyelashes, and posterior blepharitis (meibomian gland dysfunction), which involves the meibomian glands located behind the eyelashes. The condition is common, affecting up to nearly half of patients seen in eye clinics, and although more frequently noted in individuals of Northern European descent, it occurs across all populations.
The underlying mechanisms differ between the two types. In anterior blepharitis, excessive scaling of the skin at the eyelid margin, often associated with seborrheic dermatitis and colonization by organisms such as Malassezia, leads to inflammation. In posterior blepharitis, abnormal composition and secretion of lipids from the meibomian glands result in gland obstruction and inflammation. Both conditions are often influenced by genetic predisposition and may run in families.
Patients typically present with symptoms of eyelid irritation, including itching, burning, redness, and fluctuating discomfort throughout the day. Many also experience symptoms of evaporative dry eye, such as foreign body sensation and blurred vision. Those with anterior blepharitis often notice flaky debris at the base of the eyelashes, while patients with meibomian gland dysfunction may describe thick, waxy secretions along the eyelid margin or recurrent eyelid lumps such as chalazia.
On examination, anterior blepharitis is characterized by crusting and scaling at the lash line, redness of the anterior lid margin, and debris in the tear film, often accompanied by punctate keratitis. Posterior blepharitis shows plugged meibomian gland orifices with thick, yellowish secretions, diffuse lid margin redness, and abnormal tear film lipid layer. Associated findings may include telangiectatic vessels along the lid margin, chalazia, and signs of acne rosacea.
Diagnosis is clinical and based on history and slit-lamp examination. Laboratory testing is rarely required, although cultures may occasionally be performed in resistant cases. Histopathologic findings include epidermal changes and inflammatory infiltrates in anterior blepharitis, and gland obstruction with inflammatory changes in meibomian gland dysfunction.
Management focuses on long-term control rather than cure. For anterior blepharitis, the mainstay of treatment is eyelid hygiene, particularly regular eyelash scrubs using a dilute baby shampoo solution. If needed, topical antibiotic ointments may be added. For posterior blepharitis, warm compresses applied several times daily help liquefy gland secretions, followed by expression of the glands. In more persistent cases, topical azithromycin or oral doxycycline may be used, though these are avoided in young children and during pregnancy.
An important aspect of management is treating associated evaporative dry eye, which often contributes more to symptoms than the blepharitis itself. This may include artificial tears, punctal plugs, or topical anti-inflammatory therapy such as cyclosporine. Dietary supplementation with omega-3 fatty acids may also provide benefit in meibomian gland dysfunction.
Blepharitis is a lifelong condition with a tendency for recurrence, but the prognosis is excellent with appropriate management, and significant vision loss is not expected. Complications can include chronic dry eye, marginal keratitis, and chalazia. Patient education regarding the chronic nature of the disease and the importance of consistent eyelid hygiene is essential for successful long-term control.
- Published on
Ophthalmology – Blebitis
Blebitis is an infection involving a filtering bleb, which is a subconjunctival reservoir intentionally created during glaucoma surgery (such as trabeculectomy) to allow aqueous humor drainage. It is important to distinguish blebitis from bleb-associated endophthalmitis (BAE), a more severe condition in which infection extends into the vitreous. Blebitis is limited to the anterior segment, whereas BAE involves deeper intraocular structures and carries a much worse prognosis.
This condition most commonly occurs following trabeculectomy, especially when antifibrotic agents like mitomycin C are used. The incidence varies, with blebitis occurring in approximately 5.7% of such cases, while BAE is less common but more serious. Risk factors include inferiorly located blebs, thin or avascular blebs, bleb leaks, prior infections such as conjunctivitis or blepharitis, repeated surgical manipulation, and chronic antibiotic use. These factors compromise the natural protective barrier of the conjunctiva, allowing microorganisms to penetrate.
The pathophysiology differs depending on timing. Early-onset infections (within one month of surgery) are typically due to contamination during surgery, often involving less virulent organisms. Late-onset infections occur months to years later and are usually caused by more aggressive organisms that can penetrate compromised bleb tissue or enter through leaks. Common causative organisms include Staphylococcus epidermidis and Staphylococcus aureus for blebitis and early infections, while Streptococcus species, Haemophilus influenzae, and gram-negative bacteria are more common in late-onset BAE.
Patients with blebitis usually present with a red eye, mild discomfort, and possibly decreased vision. In contrast, BAE often presents abruptly with severe pain, photophobia, discharge, and rapid visual loss. On examination, blebitis is characterized by localized conjunctival injection around the bleb, a milky or cloudy appearance of the bleb, and sometimes purulent material. Anterior chamber inflammation may be present. The key distinguishing feature of BAE is vitreous involvement, often accompanied by hypopyon, which should be considered endophthalmitis until proven otherwise.
Diagnosis is primarily clinical but may be supported by additional testing. Slit-lamp examination is essential, and B-scan ultrasonography may be required if the posterior segment view is obscured. Cultures from purulent material, anterior chamber taps, or vitreous samples may help identify the causative organism, although treatment is often initiated empirically due to the urgency of the condition.
Management requires prompt and aggressive treatment. Blebitis is typically treated with intensive topical fortified antibiotics such as vancomycin and tobramycin or cefazolin, administered frequently. Mild cases may be treated with high-frequency topical fluoroquinolones. In contrast, BAE is a medical emergency requiring intravitreal antibiotics, typically vancomycin combined with ceftazidime (or amikacin if needed). Repeat intravitreal injections may be necessary, and vitrectomy is often considered. Adjunctive oral antibiotics may be used, and corticosteroids may be cautiously introduced to control inflammation.
Close follow-up is critical, often requiring daily or even multiple daily evaluations, as progression from blebitis to BAE can occur rapidly. Patients must be educated to seek immediate care for symptoms such as redness, pain, or blurred vision.
The prognosis of blebitis is generally good with early treatment, especially when caused by less virulent organisms. However, bleb-associated endophthalmitis carries a poor prognosis despite aggressive therapy, with many patients experiencing significant vision loss. Complications include bleb failure, intraocular scarring, glaucoma progression, cataract formation, retinal detachment, and, in severe cases, loss of the eye.
- Published on
Ophthalmology – Birth Trauma to the Eye
Birth trauma to the eye refers to ocular, adnexal, or facial injuries sustained during childbirth due to mechanical forces. These injuries may directly involve the eye or occur secondarily as part of broader cranial, neurologic, or facial trauma. Although relatively uncommon, birth-related injuries can have important visual consequences if not identified and managed early.
The incidence of birth trauma (both ophthalmic and non-ophthalmic) is estimated at 6–8 cases per 1,000 live births. Several risk factors increase the likelihood of such injuries, including large birth weight (especially greater than 4500 g), instrument-assisted deliveries such as forceps or vacuum extraction, prolonged or difficult labor, breech presentation, cephalopelvic disproportion, and reduced amniotic fluid (oligohydramnios). While cesarean section may be considered in high-risk cases, it does not completely eliminate the risk of injury.
The underlying pathophysiology often involves visual deprivation during a critical period of development, which can lead to amblyopia. This may result from structural abnormalities such as corneal distortion, irregular astigmatism, or eyelid ptosis that obstructs the visual axis. Injuries may be primary, directly affecting ocular tissues, or secondary, resulting from associated neurologic or vascular damage.
Clinical findings vary depending on the type and severity of injury. A classic finding is vertical or oblique breaks in Descemet’s membrane of the cornea, typically associated with forceps delivery. Other signs include an asymmetric red reflex, eyelid bruising or lacerations, conjunctival swelling (chemosis), and subconjunctival hemorrhage. Retinal hemorrhages may occur, particularly in association with intracranial trauma. Cranial nerve injuries can also be present, such as facial nerve palsy, which leads to incomplete eyelid closure, or third nerve involvement causing ptosis. Ptosis itself may arise from mechanical swelling, nerve injury, or disruption of the levator muscle.
Diagnosis is primarily clinical, based on careful ocular and neurologic examination. Neuroimaging may be required if there are associated neurologic signs. Histologically, corneal injuries reveal characteristic breaks in Descemet’s membrane. Early consultation with a pediatric ophthalmologist is essential to assess the extent of injury and prevent long-term complications.
Management depends on the specific injury. Corneal tears involving Descemet’s membrane may lead to corneal edema (hydrops) but often resolve spontaneously over weeks with observation, though monitoring for scarring is important. Superficial injuries such as abrasions or lacerations require cleaning, antibiotic ointment, and sometimes suturing. Canalicular injuries require specialized surgical repair. Facial nerve palsy is managed by protecting the cornea from exposure using frequent lubrication and, if necessary, patching. Ptosis treatment is directed at the underlying cause, with surgical correction considered when there is a risk of amblyopia.
Prognosis is generally excellent if amblyogenic factors are identified and treated early. However, complications can occur, including amblyopia due to visual deprivation, persistent ptosis, and exposure keratopathy. Early detection, close monitoring, and timely intervention are critical to preserving normal visual development.
